Lomeguatrib
Alternative Names: 4-bromothenylguanine; 4-BTG; AZD5896; PaTrin-2Latest Information Update: 05 Nov 2023
Price :
$50 *
At a glance
- Originator KuDOS Pharmaceuticals
- Class Antineoplastics; Purines
- Mechanism of Action DNA repair enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Colorectal cancer; Malignant melanoma; Solid tumours
Most Recent Events
- 04 Jul 2007 Data presented at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO-2007) added to the adverse events and Cancer therapeutic trials sections
- 01 Jun 2004 Phase-II clinical trials in Solid tumours in USA (PO)
- 20 Aug 2003 Phase-II clinical trials in Colorectal cancer in United Kingdom (PO)